Of note, LRRK2 has also been genetically implicated in several immunological disorders, namely inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis [21–23], Hansen’s disease (leprosy) [24,25], and systemic lupus erythematosus [26]. This evidence concerns the gene LRRK2 and ulcerative colitis.